MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/jnnp-2022-330519

Медицинская библиотека · Journal of neurology, neurosurgery, and psychiatry · 2023

Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis.

Uzawa Akiyuki, Suzuki Shigeaki, Kuwabara Satoshi, Akamine Hiroyuki, Onishi Yosuke, Yasuda Manato, Ozawa Yukiko, Kawaguchi Naoki, Kubota Tomoya, Takahashi Masanori P, Suzuki Yasushi, Watanabe Genya, Kimura Takashi, Sugimoto Takamichi, Samukawa Makoto, Minami Naoya, Masuda Masayuki, Konno Shingo, Nagane Yuriko, Utsugisawa Kimiaki

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Early fast-acting treatment (EFT) is the aggressive use of fast-acting therapies such as plasmapheresis, intravenous immunoglobulin and/or intravenous high-dose methylprednisolone (IVMP) from the early phases of treatment. EFT is reportedly beneficial for early achievement of minimal manifestations (MM) or better status with ≤5 mg/day prednisolone (MM5mg), a practical therapeutic target for myasthenia gravis (MG).

OBJECTIVE

The current study aimed to clarify which specific EFT regimen is efficacious and the patient characteristics that confer sensitivity to EFT.

METHODS

We recruited a total of 1710 consecutive patients with MG who enrolled in the Japan MG Registry for this large-cohort study. Among them, 1066 with generalised MG who had received immunotherapy were analysed. Prognostic background factors were matched in a 1:1 ratio using propensity score matching analysis between patients treated with EFT (n=350) and those treated without EFT (n=350). The clinical course and time to first achieve MM5mg after starting immunotherapy was analysed in relation to treatment combinations and patient characteristics.

RESULTS

Kaplan-Meier analyses showed that EFT had a significant effect on the achievement of MM5mg (p<0.0001, log-rank test; HR 1.82, p<0.0001). Notably, EFT was efficacious for any type of MG, and the inclusion of IVMP resulted in earlier and more frequent achievement of MM5mg (p=0.0352, log-rank test; HR 1.46, p=0.0380). In addition, early administration of calcineurin inhibitors also promoted MM5mg achievement.

CONCLUSION

Early cycles of intervention with EFT and early use of calcineurin inhibitors provides long-term benefits in terms of achieving therapeutic targets for generalised MG, regardless of clinical subtype.

Для цитирования: Uzawa Akiyuki, Suzuki Shigeaki, Kuwabara Satoshi, Akamine Hiroyuki, Onishi Yosuke, Yasuda Manato, Ozawa Yukiko, Kawaguchi Naoki, Kubota Tomoya, Takahashi Masanori P, Suzuki Yasushi, Watanabe Genya, Kimura Takashi, Sugimoto Takamichi, Samukawa Makoto, Minami Naoya, Masuda Masayuki, Konno Shingo, Nagane Yuriko, Utsugisawa Kimiaki. Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis.. Journal of neurology, neurosurgery, and psychiatry. 2023. DOI: 10.1136/jnnp-2022-330519.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.